RETRACTED: Inhibition of Glycogen Synthase Kinase and the Neuroprotective Function of Conjugated ZnO-Osthol Nanoparticles in Alzheimer’s Disease

<div>APP-expressing cells in culture media. Western blot analysis was used to measure A<i>β</i> expression in APP-induced BE (2)-M17 cells. Using RT-qPCR, expression levels of A<i>β</i> were measured.</div>

Bioinorganic Chemistry and Applications

fig4

Figure 4

Figure 4: RETRACTED: Inhibition of Glycogen Synthase Kinase and the Neuroprotective Function of Conjugated ZnO-Osthol Nanoparticles in Alzheimer’s Disease 

Figure 4 | RETRACTED: Inhibition of Glycogen Synthase Kinase and the Neuroprotective Function of Conjugated ZnO-Osthol Nanoparticles in Alzheimer’s Disease 